Search
for

    Research 10 of 72

    1. Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist Drug Research · 2011 · 5 citations
    2. A summary of in vitro, phase I, and phase II studies evaluating the mechanism of action, safety, and efficacy of clascoterone (cortexolone 17a propionate, CB-03-01) in androgenetic alopecia Journal of The American Academy of Dermatology · 2019 · 3 citations
    3. Cortexolone 17a-propionate: A new antiandrogen acting on hair dermal papilla cells for the treatment of androgenic alopecia Journal of The American Academy of Dermatology · 2014
    4. Cortexolone 17a-propionate: Preclinical profile of a new topical, skin selective, steroidal antiandrogen Journal of the American Academy of Dermatology · 2012
    5. Emerging Therapies for Acne Vulgaris American Journal of Clinical Dermatology · 2018 · 22 citations
    6. Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris American Journal of Clinical Dermatology · 2019 · 7 citations
    7. Differential diagnosis of trichotillomania by trichoscopy Journal of The American Academy of Dermatology · 2014
    8. A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity Clinical Pharmacology in Drug Development · 2021 · 2 citations
    9. Clascoterone as a novel treatment for androgenetic alopecia Clinical and Experimental Dermatology · 2020 · 5 citations
    10. A review of diagnosis and treatment of acne in adult female patients International Journal of Women's Dermatology · 2017 · 116 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →